Ionic liquids: A new strategy in pharmaceutical synthesis

Mini-Reviews in Organic Chemistry

Volumn 9, Issue 2, 2012, Pages 203-208

  Siódmiak, Tomasz ^a   Marszałł, Michał Piotr ^a   Proszowska, Anna ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Active pharmaceutical ingredient; Biocatalytic reaction; Green chemistry; Ionic liquid

Indexed keywords

EID: 84861130832     PISSN: 1570193X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157019312800604698     Document Type: Review

References (33)

1. http://www.emea.europa.eu/pdfs/human/ich/028395en.pdf (31-08-2010)
2. Bouder, F. Regulating impurities in pharmaceutical products: a tolerability of risk approach? Expert Rev. Clin. Pharmacol., 2008, 1, 241-250.
3. Bolt, H.M.; Foth, H.; Hengstler, J.G.; Degen, G.H. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. Toxicol. Lett., 2004, 151, 29-41.
4. Wilkes, J.S. A short history of ionic liquids-From molten salts to neoteric. Green Chem., 2002, 4, 73-80.
5. Wells, A.S.; Coombe, V.T. On the freshwater ecotoxicity and biodegradation properties of some common ionic liquids. Org. Process Res. Dev., 2006, 10, 794-798.
6. Marszałł, M.P; Kaliszan, R. Application of ionic liquids in liquid chromatography. Crit. Rev. Anal. Chem., 2007, 37, 127-140.
7. Van Rantwijk, F.; Sheldon, R.A. Biocatalysis in ionic liquids. Chem. Rev. 2007, 107, 2757-2785.
8. Marszałł, M.P.; Markuszewski M.J.; Kaliszan R. Separation of nicotinic acid and its structural isomers using 1-ethyl-3-methylimidazolium ionic liquid as a buffer additive by capillary electrophoresis. J. Pharm. Biomed. Anal., 2006, 42, 3.
9. Studzinska, S.; Buszewski, B. Study of toxicity of imidazolium ionic liquids to watercress (Lepidium sativum L.). Anal. Bioanal. Chem., 2009, 393, 983-990.
10. Rogers, R.D.; Seddon, K.R. Ionic liquids IIIB: Fundamentals, progress, challenges, and opportunities-transformations and processes. Am. Chem. Soc., 2005, ACS Symposium Series 902.
11. Van Rantwijk, F.; Lau, R.M.; Sheldon, R.A. Biocatalytic transformations ionic liquids. Trends Biotechnol.,2003, 21.
12. Sheldon, R.A.; Arends I.; Hanefeld U. Green Chemistry and Catalysis, Wiley-VCH, 2007.
13. Lozano, P.; De Diego, T.; Iborra, J.L. Methods in Biotechnology: Immobilization of Enzymes and Cells, 2rd ed., Humana Press, Inc.: New Jersey, 2006.
14. Kaftzik, N.; Wasserscheid, P.; Kragl, U. Use of ionic liquids to increase the yield and enzyme stability in the β- Galactosidase catalysed synthesis of Nacetyllactosamine. Org. Process Dev., 2002, 6, 553-557.
15. Erbeldinger, M.; Mesiano, A.J.; Russell, A.J. Enzymatic catalysis of formation of Z-aspartame in ionic liquid - an alternative to enzymatic catalysis in organic solvents. Biotechnol. Prog., 2000, 16, 1129-1131.
16. Earle, M.J.; Seddon, K.R. Ionic liquids. Green solvents for the future. Pure Appl. Chem., 2000, 72, 1391-1398.
17. Cull, S.G.; Holbrey, J.D.; Vargas-Mora, V.; Seddon, K.R.; Lye, G.J. Roomtemperature ionic liquids as replacements for organic solvents in multiphase bioprocess operations. Biotechnol. Bioeng., 2000, 69, 2.
18. Prasad, A.K.; Kumar, V.; Malhotra, S.; Ravikumar, V.T.; Sanghvi, Y.S.; Parma, V.S. 'Green' methodology for efficient and selective benzoylation ofnucleosides using benzoyl cyanide in an ionic liquid. Bioorg. Med. Chem., 2005, 13, 4467.
19. Kumar, V.; Parmar, V.S.; Malhotra, S.V. Enhanced solubility and selective benzoylation of nucleosides in novel ionic liquid. Tetrahedron Lett., 2007, 48, 809.
20. Kumar, V.; Malhotra, S.V. Synthesis of nucleoside-based antiviral drugs in ionic liquids. Bioorg. Med. Chem. Lett., 2008, 5640-5642.
21. Gueiffier, A.; Lhassani, M.; Elhakmaoui, A.; Snoeck, R.; Andrei, G.; Chavignon, O.; Teulade, J.-C.; Kerbal, A.; Essassi, E. M.; Debouzy, J.-C.; Witvrouw, M.; Blache, Y.; Balzarini, J.; De Clercq, E.; Chapat, J.-P. Synthesis of Acyclo-C-nucleosides in the Imidazo[1,2-a]pyridine and Pyrimidine Series as Antiviral Agents. J. Med. Chem., 1996, 39, 2856-2859.
22. Shaabani, A.; Soleimani, E.; Maleki, A.; Ionic liquid promoted one-pot synthesis of 3-aminoimidazo[1,2-a]pyridines. Tetrahedron Lett., 2006, 47, 3031-3034.
23. Fan, X.; Feng, D.; Qu, Y.; Zhang, X., Wang, J.; Loiseau, P.M.; Andrei, G.; Sneck, R.; De Clercq, E. Practical and efficient synthesis of pyrano[3,2-c]pyridine, pyrano[4,3-b]pyran and their hybrids with nucleoside as potential antiviral and antileishmanial agents. Bioorg. Med. Chem. Lett., 2010, 809-813.
24. Zhang, X.; Li, X.; Li, D.; Qu, G.; Wang, J.; Loiseau, P.M.; Fan, X. Ionic liquid mediated and promoted eco-friendly preparation of thiazalidinone and pyrimidine nucleoside-thiazolidinone hybrids and their antiparasitic activities. Bioorg. Med. Chem. Lett., 2009, 6280-6283.
25. Zaidlewicz, M.; Cytarska, J.; Dzieleńdziak, A.; Ziegler-Borowska, M. Synthesis of boronated phenylalanine analogues with a quaternary center for boron neutron capture therapy. ARKIVOC, 2004, iii, 11-21.
26. Wolan, A.; Zaidlewicz, M. Synthesis of aryloboronates by the palladium catalysed cross-coupling reaction in ionic liquids. Org.Biomol. Chem., 2003, 1, 3274.
27. Kurata, A.; Kitamura, Y.; Irie, S.; Takemoto, S.; Akai, Y.; Hirota, Y.; Fujita, T.; Iwai, K.; Fursawa, M.; Kishimoto, N. Enzymatic synthesis of caffeic acid phenethyl ester analogues in ionic liquid. J. Biotechnol., 2010, 133-138.
28. Earle, M.J.; McCormac, P.B.; Seddon, K.R. The first high yield green route to a pharmaceutical in a room temperature ionic liquid. Green Chem., 2000, 2, 261-262.
29. Monteiro, A.L.; Zinn, F.K., de Souza R.F.; Dupont J. Asymmetric hydrogenation of 2-arylacrylic acids catalized by immobilized Ru-BINAP complex in 1-n-butyl-3-methylimidazolium tetrafluoroborate molten salt. Tetrahedron: Asymmetry,1997, 8, 177-179.
30. Adams, S.S.; Bresloff, P.; Mason, G.C. Pharmacological Difference between the Optical Isomers of Ibuprofen: Evidence for Metabolic Inversion of the (-) Isomer. J. Pharm. Pharmacol.,1976, 28, 156-157.
31. Yu, H.; Wu, J.; Ching, C.B. Kinetic resolution of Ibuprofen catalyzed by Candida rugosa Lipase in ionic liquids. Chirality, 2005, 17, 16-21.
32. Contesini, F.J.; Carvalho, P.O. Estrification of (R,S)-Ibuprofen by native and commercial lipases in a two-phase system containing ionic liquids. Tetrahedron: Asymmetry, 2006, 17, 2069-2073.
33. Choi, H.K.; Uhm, K.N.; Kim, H.K.; Production of chiral compound using recombinant Escherichia coli cells co-expressing reductase and glucose dehydrogenase in an ionic liquid/water two phase system. J. Mol. Catal. B: Enz., 2011, 114-118.